Literature DB >> 29961049

The Microbiome and Acute Kidney Injury.

Hamid Rabb1, Jennifer Pluznick2, Sanjeev Noel1.   

Abstract

Acute kidney injury (AKI) is a major clinical problem in native and transplanted kidneys. Bidirectional interaction between gut microbiota and kidney tissue or the "colo-renal" system is being recognized as an important modulating factor in AKI. Gut microbes appear to have a complex but yet poorly understood communication with renal cellular and molecular processes that affect normal kidney function and response to injury. There have been major recent advances in the study of the microbiome that provide an opportunity to apply this knowledge to improve our understanding and treatment of patients with AKI. This mini-review aims to focus on select general concepts about the microbiome, mechanisms by which the microbiome can modify kidney function, and data on microbiome and AKI. We have briefly touched on a few topics rather than comprehensively reviewing the role of microbiome in kidney diseases. We also propose future gut microbiota-AKI studies based on advances in gut microbiota studies in other human diseases and experimental models.
© 2018 S. Karger AG, Basel.

Entities:  

Keywords:  Acute kidney injury; Colo-renals; Intestinal microbiota; Olfactory receptor; Short chain fatty acid

Mesh:

Year:  2018        PMID: 29961049      PMCID: PMC6292672          DOI: 10.1159/000490392

Source DB:  PubMed          Journal:  Nephron        ISSN: 1660-8151            Impact factor:   2.847


  15 in total

1.  Gut Bacteria Products Prevent AKI Induced by Ischemia-Reperfusion.

Authors:  Vinicius Andrade-Oliveira; Mariane T Amano; Matheus Correa-Costa; Angela Castoldi; Raphael J F Felizardo; Danilo C de Almeida; Enio J Bassi; Pedro M Moraes-Vieira; Meire I Hiyane; Andrea C D Rodas; Jean P S Peron; Cristhiane F Aguiar; Marlene A Reis; Willian R Ribeiro; Claudete J Valduga; Rui Curi; Marco Aurelio Ramirez Vinolo; Caroline M Ferreira; Niels Olsen Saraiva Câmara
Journal:  J Am Soc Nephrol       Date:  2015-01-14       Impact factor: 10.121

2.  Microbial exposure during early life has persistent effects on natural killer T cell function.

Authors:  Torsten Olszak; Dingding An; Sebastian Zeissig; Miguel Pinilla Vera; Julia Richter; Andre Franke; Jonathan N Glickman; Reiner Siebert; Rebecca M Baron; Dennis L Kasper; Richard S Blumberg
Journal:  Science       Date:  2012-03-22       Impact factor: 47.728

3.  Depletion of Gut Microbiota Protects against Renal Ischemia-Reperfusion Injury.

Authors:  Diba Emal; Elena Rampanelli; Ingrid Stroo; Loes M Butter; Gwendoline J Teske; Nike Claessen; Geurt Stokman; Sandrine Florquin; Jaklien C Leemans; Mark C Dessing
Journal:  J Am Soc Nephrol       Date:  2016-12-07       Impact factor: 10.121

Review 4.  Intestinal microbiota-kidney cross talk in acute kidney injury and chronic kidney disease.

Authors:  Sanjeev Noel; Maria N Martina-Lingua; Samatha Bandapalle; Jennifer Pluznick; Abdel Rahim A Hamad; Daniel A Peterson; Hamid Rabb
Journal:  Nephron Clin Pract       Date:  2014-09-24

5.  Chronic kidney disease alters intestinal microbial flora.

Authors:  Nosratola D Vaziri; Jakk Wong; Madeleine Pahl; Yvette M Piceno; Jun Yuan; Todd Z DeSantis; Zhenmin Ni; Tien-Hung Nguyen; Gary L Andersen
Journal:  Kidney Int       Date:  2012-09-19       Impact factor: 10.612

6.  Evaluation of the impact of gut microbiota on uremic solute accumulation by a CE-TOFMS-based metabolomics approach.

Authors:  Eikan Mishima; Shinji Fukuda; Chikahisa Mukawa; Akinori Yuri; Yoshitomi Kanemitsu; Yotaro Matsumoto; Yasutoshi Akiyama; Noriko N Fukuda; Hiroki Tsukamoto; Kei Asaji; Hisato Shima; Koichi Kikuchi; Chitose Suzuki; Takehiro Suzuki; Yoshihisa Tomioka; Tomoyoshi Soga; Sadayoshi Ito; Takaaki Abe
Journal:  Kidney Int       Date:  2017-04-08       Impact factor: 10.612

7.  Microbial short chain fatty acid metabolites lower blood pressure via endothelial G protein-coupled receptor 41.

Authors:  Niranjana Natarajan; Daijiro Hori; Sheila Flavahan; Jochen Steppan; Nicholas A Flavahan; Dan E Berkowitz; Jennifer L Pluznick
Journal:  Physiol Genomics       Date:  2016-09-23       Impact factor: 3.107

8.  Rifaximin Decreases the Incidence and Severity of Acute Kidney Injury and Hepatorenal Syndrome in Cirrhosis.

Authors:  Tien Dong; Andrew Aronsohn; K Gautham Reddy; Helen S Te
Journal:  Dig Dis Sci       Date:  2016-09-21       Impact factor: 3.199

9.  Olfactory receptor responding to gut microbiota-derived signals plays a role in renin secretion and blood pressure regulation.

Authors:  Jennifer L Pluznick; Ryan J Protzko; Haykanush Gevorgyan; Zita Peterlin; Arnold Sipos; Jinah Han; Isabelle Brunet; La-Xiang Wan; Federico Rey; Tong Wang; Stuart J Firestein; Masashi Yanagisawa; Jeffrey I Gordon; Anne Eichmann; Janos Peti-Peterdi; Michael J Caplan
Journal:  Proc Natl Acad Sci U S A       Date:  2013-02-11       Impact factor: 11.205

10.  Impact of maintenance immunosuppressive therapy on the fecal microbiome of renal transplant recipients: Comparison between an everolimus- and a standard tacrolimus-based regimen.

Authors:  Gianluigi Zaza; Alessandra Dalla Gassa; Giovanna Felis; Simona Granata; Sandra Torriani; Antonio Lupo
Journal:  PLoS One       Date:  2017-05-24       Impact factor: 3.240

View more
  9 in total

1.  Genetic Deletion of LRP5 and LRP6 in Macrophages Exacerbates Colitis-Associated Systemic Inflammation and Kidney Injury in Response to Intestinal Commensal Microbiota.

Authors:  Indumathi Manoharan; Daniel Swafford; Arulkumaran Shanmugam; Nikhil Patel; Puttur D Prasad; Riyaz Mohamed; Qingqing Wei; Zheng Dong; Muthusamy Thangaraju; Santhakumar Manicassamy
Journal:  J Immunol       Date:  2022-06-27       Impact factor: 5.426

Review 2.  Role of T cells in ischemic acute kidney injury and repair.

Authors:  Kyungho Lee; Hye Ryoun Jang
Journal:  Korean J Intern Med       Date:  2022-04-28       Impact factor: 3.165

3.  Zengye Decoction Attenuated Severe Acute Pancreatitis Complicated with Acute Kidney Injury by Modulating the Gut Microbiome and Serum Amino Acid Metabolome.

Authors:  Xiao-Yu Dai; Qian Hu; Jia-Qi Yao; Xiao-Jia Wu; Yi-Fan Miao; Juan Li; Mei-Hua Wan; Wen-Fu Tang
Journal:  Evid Based Complement Alternat Med       Date:  2022-05-09       Impact factor: 2.650

Review 4.  Sepsis and the Microbiome: A Vicious Cycle.

Authors:  William D Miller; Robert Keskey; John C Alverdy
Journal:  J Infect Dis       Date:  2021-06-16       Impact factor: 5.226

Review 5.  The Use of Immune Checkpoint Inhibitors in Oncology and the Occurrence of AKI: Where Do We Stand?

Authors:  Rossana Franzin; Giuseppe Stefano Netti; Federica Spadaccino; Camillo Porta; Loreto Gesualdo; Giovanni Stallone; Giuseppe Castellano; Elena Ranieri
Journal:  Front Immunol       Date:  2020-10-08       Impact factor: 7.561

6.  Characteristics of the intestinal microbiome in ankylosing spondylitis.

Authors:  Anca Cardoneanu; Sebastian Cozma; Ciprian Rezus; Florin Petrariu; Alexandra Maria Burlui; Elena Rezus
Journal:  Exp Ther Med       Date:  2021-04-24       Impact factor: 2.447

7.  Probiotics partially attenuate the severity of acute kidney injury through an immunomodulatory effect.

Authors:  Jihyun Yang; Geun Eog Ji; Myeong Soo Park; Yeong-Je Seong; Yoon Sook Go; Hee Young Lee; Yina Fang; Myung-Gyu Kim; Se Won Oh; Won Yong Cho; Sang-Kyung Jo
Journal:  Kidney Res Clin Pract       Date:  2021-11-25

Review 8.  Intestinal microbiota dysbiosis in acute kidney injury: novel insights into mechanisms and promising therapeutic strategies.

Authors:  Juan Lei; Yifan Xie; Jingyi Sheng; Jiayu Song
Journal:  Ren Fail       Date:  2022-12       Impact factor: 2.606

9.  Microbiome-Metabolome Signature of Acute Kidney Injury.

Authors:  Nadezda V Andrianova; Vasily A Popkov; Natalia S Klimenko; Alexander V Tyakht; Galina V Baydakova; Olga Y Frolova; Ljubava D Zorova; Irina B Pevzner; Dmitry B Zorov; Egor Y Plotnikov
Journal:  Metabolites       Date:  2020-04-04
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.